Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Double-blind, Placebo-controlled Comparative Study of the Efficacy and Safety of the Drug Dimephosphon®, Concentrate for Solution for Intravenous Administration, 1 g, in Acute Ischemic Stroke Patients

NCT07167550 is registered in ClinicalTrials.gov with Tatchempharmpreparaty, JSC as lead sponsor.

NCT NCT07167550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07167550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Double-blind, Placebo-controlled Comparative Study of the Efficacy and Safety of the Drug Dimephosphon®, Concentrate for Solution for Intravenous Administration, 1 g, in Acute Ischemic Stroke Patients
Lead sponsor
Tatchempharmpreparaty, JSC
Phase
Phase 3
Overall status
Recruiting
Start date
September 6, 2025
Completion date
April 30, 2026
Enrollment
184 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke, cerebrovascular disorders, ischemic stroke, physiological effects of drugs, stroke